The UK’s pharma manufacturing base still has potential, but only if companies modernize operations, boost efficiency, and show global investors that the UK can compete on cost and capability.
6
min read
Newsletters
Receive the latest pharmaceutical news, personalities, education, and career development – weekly to your inbox.